Immunogen, Inc. Share Price: IMGN (Immunogen, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Immunogen, Inc. share price today?

Accepted Answer

Immunogen, Inc. (IMGN) share price today is {{live_price}}.

Question 2

Can Indians buy Immunogen, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Immunogen, Inc. (IMGN) from India.

With INDmoney, you can buy Immunogen, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Immunogen, Inc. at zero transaction cost.

Question 3

How can I buy Immunogen, Inc. shares from India?

Accepted Answer

It is very easy to buy Immunogen, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Immunogen, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Immunogen, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Immunogen, Inc. stocks?

Accepted Answer

To start investing in Immunogen, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Immunogen, Inc.

Accepted Answer

Today’s highest price of Immunogen, Inc. (IMGN) is {{1_rba_end}}.

Today’s lowest price of Immunogen, Inc. (IMGN) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Immunogen, Inc.

Accepted Answer

Today's market capitalisation of Immunogen, Inc. IMGN is 4.0B

Question 8

What is the 52 Week High and Low Range of Immunogen, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Immunogen, Inc. is down from its 52 Week High?

Accepted Answer

Immunogen, Inc. (IMGN) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Immunogen, Inc. is up from its 52 Week low?

Accepted Answer

Immunogen, Inc. (IMGN) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Immunogen, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Immunogen, Inc.

Accepted Answer

Mr. Mark Joseph Enyedy is the current Chief Executive Officer (CEO) of Immunogen, Inc..

Period	Immunogen, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	3.99%	-2.6%	0.0%
6 Months	20.15%	2.2%	0.0%
1 Year	218.11%	-4.3%	-3.4%
3 Years	196.51%	19.1%	-4.7%

Market Capitalization	4.0B
Book Value	$2.06
Dividend Share	0.0
Dividend Yield	1.13%
Earnings Per Share (EPS)	-0.28
PEG Ratio	0.0
Wall Street Target Price	23.46

Profit Margin	-25.56%
Operating Margin TTM	22.88%

Return On Assets TTM	-8.49%
Return On Equity TTM	-19.88%

Revenue TTM	287.6M
Revenue Per Share TTM	1.1
Quarterly Revenue Growth YOY	637.6999999999999%
Gross Profit TTM	-104.8M
EBITDA	-78.5M
Diluted Eps TTM	-0.28
Quarterly Earnings Growth YOY	4.08

Immunogen, Inc. (IMGN)

Increasing Revenue

Increasing Net Profit

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Immunogen, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	0.06
EPS Estimate Next Year	0.35
EPS Estimate Current Quarter	0.04
EPS Estimate Next Quarter	0.07

	FY17	Y/Y Change
Revenue	115.4M	↑ 92.41%
Net Income	-96.0M	↓ 33.16%
Net Profit Margin	-83.17%	↑ 156.25%

	FY18	Y/Y Change
Revenue	53.8M	↓ 53.38%
Net Income	-167.9M	↑ 74.85%
Net Profit Margin	-311.94%	↓ 228.77%

	FY19	Y/Y Change
Revenue	82.3M	↑ 52.87%
Net Income	-122.1M	↓ 27.27%
Net Profit Margin	-148.4%	↑ 163.54%

	FY20	Y/Y Change
Revenue	132.3M	↑ 60.81%
Net Income	-66.7M	↓ 45.38%
Net Profit Margin	-50.4%	↑ 98.0%

	FY21	Y/Y Change
Revenue	69.9M	↓ 47.2%
Net Income	-149.4M	↑ 123.98%
Net Profit Margin	-213.81%	↓ 163.41%

	FY22	Y/Y Change
Revenue	108.8M	↑ 55.72%
Net Income	-222.9M	↑ 49.26%
Net Profit Margin	-204.93%	↑ 8.88%

	Q2 FY22	Q/Q Change
Revenue	14.2M	↓ 62.81%
Net Income	-63.0M	↑ 147.62%
Net Profit Margin	-444.77%	↓ 377.97%

	Q3 FY22	Q/Q Change
Revenue	15.4M	↑ 8.57%
Net Income	-78.1M	↑ 23.96%
Net Profit Margin	-507.84%	↓ 63.07%

	Q4 FY22	Q/Q Change
Revenue	41.2M	↑ 167.75%
Net Income	-59.0M	↓ 24.43%
Net Profit Margin	-143.34%	↑ 364.5%

	FY17	Y/Y Change
Total Assets	294.7M	↑ 2.64%
Total Liabilities	312.6M	↓ 15.11%

	FY18	Y/Y Change
Total Assets	295.8M	↑ 0.36%
Total Liabilities	283.8M	↓ 9.2%

	FY19	Y/Y Change
Total Assets	235.7M	↓ 20.32%
Total Liabilities	311.8M	↑ 9.86%

	FY20	Y/Y Change
Total Assets	355.1M	↑ 50.67%
Total Liabilities	265.5M	↓ 14.84%

	Q1 FY23	Q/Q Change
Revenue	49.9M	↑ 21.14%
Net Income	-40.6M	↓ 31.25%
Net Profit Margin	-81.35%	↑ 61.99%

	Q2 FY23	Q/Q Change
Revenue	83.2M	↑ 66.74%
Net Income	-4.2M	↓ 89.53%
Net Profit Margin	-5.11%	↑ 76.24%

	Q3 FY23	Q/Q Change
Revenue	113.4M	↑ 36.41%
Net Income	30.7M	↓ 823.82%
Net Profit Margin	27.11%	↑ 32.22%

	FY21	Y/Y Change
Total Assets	525.8M	↑ 48.07%
Total Liabilities	200.2M	↓ 24.6%

	FY22	Y/Y Change
Total Assets	348.9M	↓ 33.63%
Total Liabilities	193.1M	↓ 3.53%

	Q2 FY22	Q/Q Change
Total Assets	422.3M	↓ 12.33%
Total Liabilities	172.5M	↓ 1.58%

	Q3 FY22	Q/Q Change
Total Assets	358.8M	↓ 15.04%
Total Liabilities	180.8M	↑ 4.83%

	Q1 FY23	Q/Q Change
Total Assets	288.3M	↓ 17.36%
Total Liabilities	166.4M	↓ 13.82%

	Q2 FY23	Q/Q Change
Total Assets	714.3M	↑ 147.73%
Total Liabilities	223.5M	↑ 34.28%

	Q3 FY23	Q/Q Change
Total Assets	822.1M	↑ 15.09%
Total Liabilities	260.5M	↑ 16.56%

	FY17	Y/Y Change
Operating Cash Flow	7.6M	↓ 106.14%
Investing Cash Flow	-1.1M	↓ 83.23%
Financing Cash Flow	100.6M	↓ 1.13%

	FY18	Y/Y Change
Operating Cash Flow	-166.4M	↓ 2276.87%
Investing Cash Flow	-5.2M	↑ 370.07%
Financing Cash Flow	166.8M	↑ 65.8%

	FY19	Y/Y Change
Operating Cash Flow	-88.4M	↓ 46.9%
Investing Cash Flow	-533.0K	↓ 89.84%
Financing Cash Flow	2.9M	↓ 98.28%

	FY20	Y/Y Change
Operating Cash Flow	-78.6M	↓ 11.03%
Investing Cash Flow	509.0K	↓ 195.5%
Financing Cash Flow	195.7M	↑ 6713.16%

	FY21	Y/Y Change
Operating Cash Flow	-169.4M	↑ 115.49%
Investing Cash Flow	-1.4M	↓ 381.73%
Financing Cash Flow	355.7M	↑ 81.74%

	FY22	Y/Y Change
Operating Cash Flow	-229.8M	↑ 35.64%
Investing Cash Flow	-1.4M	↓ 4.88%
Financing Cash Flow	27.6M	↓ 92.25%

	Q1 FY22	Q/Q Change
Operating Cash Flow	-41.4M	↓ 9.75%
Investing Cash Flow	-307.0K	↓ 16.8%
Financing Cash Flow	620.0K	↓ 99.78%

	Q2 FY22	Q/Q Change
Operating Cash Flow	-64.0M	↑ 54.56%
Investing Cash Flow	-207.0K	↓ 32.57%
Financing Cash Flow	411.0K	↓ 33.71%

	Q3 FY22	Q/Q Change
Operating Cash Flow	-64.2M	↑ 0.34%
Investing Cash Flow	-602.0K	↑ 190.82%
Financing Cash Flow	449.0K	↑ 9.25%

	Q4 FY22	Q/Q Change
Operating Cash Flow	-60.2M	↓ 6.25%
Investing Cash Flow	-248.0K	↓ 58.8%
Financing Cash Flow	26.1M	↑ 5707.13%